Skip to main content
Erschienen in: The International Journal of Cardiovascular Imaging 11/2023

24.10.2023 | Original Paper

Inter- and intra-observer reproducibility of CT-Leaman score by an independent core lab

verfasst von: Pruthvi C. Revaiah, Shigetaka Kageyama, Shinichiro Masuda, Kai Ninomiya, Nozomi Kotoku, Bo Wang, Xingqiang He, Tsung-Ying Tsai, Scot Garg, Saima Mushtaq, Johan H. C. Reiber, David M. Leaman, Jeroen J. Bax, Matthew J. Budoff, Daniele Andreini, Patrick W. Serruys, Yoshinobu Onuma

Erschienen in: The International Journal of Cardiovascular Imaging | Ausgabe 11/2023

Einloggen, um Zugang zu erhalten

Abstract

To assess the reproducibility of CT-based Leaman score (CT-LeSc). CT-LeSc can non-invasively quantify total coronary atherosclerotic burden and is an independent long-term predictor of cardiac events. Its calculation however relies on the subjective assessment of lesions using coronary computed tomography angiography and therefore is subject to intra- and inter-observer variability. Inter-observer reproducibility was assessed by calculating the CT-LeSc in 50 patients randomly selected from the SYNTAX III REVOLUTION and ABSORB trials by two separate teams, each made up of two cardiologists, who reported results by consensus. For intra-observer reproducibility, the CT-LeSc was calculated in same 50 patients on two occasions eight weeks apart, by the same team of two cardiologists. The level of agreement was measured by the weighted kappa statistic, with intra- and inter-observer variability used to evaluate the CT-LeSc’s reproducibility. The variables evaluated by weighted kappa statistics were total number of lesions; number of calcified lesions; number of non-calcified lesions; number of mixed lesions; number of obstructive lesions; number of non-obstructive lesions; and the total CT-LeSc in increments of ten and five. During assessment of inter-observer variability the mean ± standard deviation (SD) CT-LeSc calculated by the first and second team was 15.36 ± 5.57 versus 15.24 ± 5.16. The mean of the differences (precision) was 0.97, with a SD (accuracy) 1.17. The inter-observer variability was lowest for Leaman score in increments of five (weighted kappa 0.93), and highest for the total number of calcified lesions (weighted kappa 0.66). During assessment of intra-observer variability, the mean ± SD CT-LeSc were 16.61 ± 5.28 versus 16.82 ± 5.55. The mean ± SD of the differences was 1.28 ± 1.02. The intra-observer variability was the lowest for Leaman score in increments of five (weighted kappa 0.93), and the highest for the total number of lesions and calcified lesions (weighted kappa 0.65). CT-LeSc has substantial to near-perfect agreement for reproducibility.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Leaman DM, Brower RW, Meester GT, Serruys P, van den Brand M (1981) Coronary artery atherosclerosis: severity of the disease, severity of angina pectoris and compromised left ventricular function. Circulation 63:285–299CrossRefPubMed Leaman DM, Brower RW, Meester GT, Serruys P, van den Brand M (1981) Coronary artery atherosclerosis: severity of the disease, severity of angina pectoris and compromised left ventricular function. Circulation 63:285–299CrossRefPubMed
2.
Zurück zum Zitat Shaw LJ, Blankstein R, Bax JJ et al (2021) Society of cardiovascular computed tomography/North American society of cardiovascular imaging–expert consensus document on coronary CT imaging of atherosclerotic plaque. J Cardiovasc Comput Tomogr 15:93–109CrossRefPubMed Shaw LJ, Blankstein R, Bax JJ et al (2021) Society of cardiovascular computed tomography/North American society of cardiovascular imaging–expert consensus document on coronary CT imaging of atherosclerotic plaque. J Cardiovasc Comput Tomogr 15:93–109CrossRefPubMed
3.
Zurück zum Zitat Williams MC, Moss AJ, Dweck M et al (2019) Coronary artery plaque characteristics associated with adverse outcomes in the SCOT-HEART study. J Am Coll Cardiol 73:291–301CrossRefPubMedPubMedCentral Williams MC, Moss AJ, Dweck M et al (2019) Coronary artery plaque characteristics associated with adverse outcomes in the SCOT-HEART study. J Am Coll Cardiol 73:291–301CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Mortensen MB, Dzaye O, Steffensen FH et al (2020) Impact of plaque burden versus stenosis on ischemic events in patients with coronary atherosclerosis. J Am Coll Cardiol 76:2803–2813CrossRefPubMed Mortensen MB, Dzaye O, Steffensen FH et al (2020) Impact of plaque burden versus stenosis on ischemic events in patients with coronary atherosclerosis. J Am Coll Cardiol 76:2803–2813CrossRefPubMed
5.
Zurück zum Zitat Inoue K, Motoyama S, Sarai M et al (2010) Serial coronary CT angiography-verified changes in plaque characteristics as an end point: evaluation of effect of statin intervention. JACC Cardiovasc Imaging 3:691–698CrossRefPubMed Inoue K, Motoyama S, Sarai M et al (2010) Serial coronary CT angiography-verified changes in plaque characteristics as an end point: evaluation of effect of statin intervention. JACC Cardiovasc Imaging 3:691–698CrossRefPubMed
6.
Zurück zum Zitat van Rosendael AR, van den Hoogen IJ, Gianni U et al (2021) Association of statin treatment with progression of coronary atherosclerotic plaque composition. JAMA Cardiol 6:1257–1266CrossRefPubMed van Rosendael AR, van den Hoogen IJ, Gianni U et al (2021) Association of statin treatment with progression of coronary atherosclerotic plaque composition. JAMA Cardiol 6:1257–1266CrossRefPubMed
7.
Zurück zum Zitat Mushtaq S, De Araujo Gonçalves P, Garcia-Garcia HM et al (2015) Long-term prognostic effect of coronary atherosclerotic burden: validation of the computed tomography-leaman score. Circ Cardiovasc Imaging 8:e002332CrossRefPubMed Mushtaq S, De Araujo Gonçalves P, Garcia-Garcia HM et al (2015) Long-term prognostic effect of coronary atherosclerotic burden: validation of the computed tomography-leaman score. Circ Cardiovasc Imaging 8:e002332CrossRefPubMed
8.
Zurück zum Zitat Andreini D, Pontone G, Mushtaq S et al (2017) Long-term prognostic impact of CT-Leaman score in patients with non-obstructive CAD: results from the coronary CT angiography evaluation for clinical outcomes International multicenter (CONFIRM) study. Int J Cardiol 231:18–25CrossRefPubMed Andreini D, Pontone G, Mushtaq S et al (2017) Long-term prognostic impact of CT-Leaman score in patients with non-obstructive CAD: results from the coronary CT angiography evaluation for clinical outcomes International multicenter (CONFIRM) study. Int J Cardiol 231:18–25CrossRefPubMed
9.
Zurück zum Zitat Collet C, Onuma Y, Andreini D et al (2018) Coronary computed tomography angiography for heart team decision-making in multivessel coronary artery disease. Eur Heart J 39:3689–3698PubMedPubMedCentral Collet C, Onuma Y, Andreini D et al (2018) Coronary computed tomography angiography for heart team decision-making in multivessel coronary artery disease. Eur Heart J 39:3689–3698PubMedPubMedCentral
10.
Zurück zum Zitat Onuma Y, Grundeken MJ, Nakatani S et al (2017) Serial 5-year evaluation of side branches jailed by bioresorbable vascular scaffolds using 3-dimensional optical coherence tomography: insights from the ABSORB cohort B trial (a clinical evaluation of the bioabsorbable everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions). Circ Cardiovasc Interv. https://doi.org/10.1161/CIRCINTERVENTIONS.116.004393CrossRefPubMed Onuma Y, Grundeken MJ, Nakatani S et al (2017) Serial 5-year evaluation of side branches jailed by bioresorbable vascular scaffolds using 3-dimensional optical coherence tomography: insights from the ABSORB cohort B trial (a clinical evaluation of the bioabsorbable everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions). Circ Cardiovasc Interv. https://​doi.​org/​10.​1161/​CIRCINTERVENTION​S.​116.​004393CrossRefPubMed
11.
Zurück zum Zitat de Araújo Gonçalves P, Garcia-Garcia HM, Dores H et al (2013) Coronary computed tomography angiography-adapted Leaman score as a tool to noninvasively quantify total coronary atherosclerotic burden. Int J Cardiovasc Imaging 29:1575–1584CrossRefPubMed de Araújo Gonçalves P, Garcia-Garcia HM, Dores H et al (2013) Coronary computed tomography angiography-adapted Leaman score as a tool to noninvasively quantify total coronary atherosclerotic burden. Int J Cardiovasc Imaging 29:1575–1584CrossRefPubMed
12.
Zurück zum Zitat Ozaki Y, Garcia-Garcia HM, Rogers T et al (2020) Coronary artery disease assessed by computed tomography-based Leaman score in patients with low-risk transcatheter aortic valve implantation. Am J Cardiol 125:1216–1221CrossRefPubMed Ozaki Y, Garcia-Garcia HM, Rogers T et al (2020) Coronary artery disease assessed by computed tomography-based Leaman score in patients with low-risk transcatheter aortic valve implantation. Am J Cardiol 125:1216–1221CrossRefPubMed
13.
Zurück zum Zitat Nicol ED, Stirrup J, Roughton M, Padley SP, Rubens MB (2009) 64-Channel cardiac computed tomography: intraobserver and interobserver variability (part 1): coronary angiography. J Comput Assist Tomogr 33:161–168CrossRefPubMed Nicol ED, Stirrup J, Roughton M, Padley SP, Rubens MB (2009) 64-Channel cardiac computed tomography: intraobserver and interobserver variability (part 1): coronary angiography. J Comput Assist Tomogr 33:161–168CrossRefPubMed
14.
Zurück zum Zitat Ferencik M, Nieman K, Achenbach S (2006) Noncalcified and calcified coronary plaque detection by contrast-enhanced multi-detector computed tomography: a study of interobserver agreement. J Am Coll Cardiol 47:207–209CrossRefPubMed Ferencik M, Nieman K, Achenbach S (2006) Noncalcified and calcified coronary plaque detection by contrast-enhanced multi-detector computed tomography: a study of interobserver agreement. J Am Coll Cardiol 47:207–209CrossRefPubMed
15.
Zurück zum Zitat Stolzmann P, Scheffel H, Leschka S et al (2008) Influence of calcifications on diagnostic accuracy of coronary CT angiography using prospective ECG triggering. Am J Roentgenol 191:1684–1689CrossRef Stolzmann P, Scheffel H, Leschka S et al (2008) Influence of calcifications on diagnostic accuracy of coronary CT angiography using prospective ECG triggering. Am J Roentgenol 191:1684–1689CrossRef
16.
Zurück zum Zitat Williams MC, Golay SK, Hunter A et al (2015) Observer variability in the assessment of CT coronary angiography and coronary artery calcium score: substudy of the scottish COmputed tomography of the HEART (SCOT-HEART) trial. Open Heart 2:e000234CrossRefPubMedPubMedCentral Williams MC, Golay SK, Hunter A et al (2015) Observer variability in the assessment of CT coronary angiography and coronary artery calcium score: substudy of the scottish COmputed tomography of the HEART (SCOT-HEART) trial. Open Heart 2:e000234CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Hoffmann H, Frieler K, Hamm B, Dewey M (2008) Intra- and interobserver variability in detection and assessment of calcified and noncalcified coronary artery plaques using 64-slice computed tomography: variability in coronary plaque measurement using MSCT. Int J Cardiovasc Imaging 24:735–742CrossRefPubMed Hoffmann H, Frieler K, Hamm B, Dewey M (2008) Intra- and interobserver variability in detection and assessment of calcified and noncalcified coronary artery plaques using 64-slice computed tomography: variability in coronary plaque measurement using MSCT. Int J Cardiovasc Imaging 24:735–742CrossRefPubMed
18.
Zurück zum Zitat Cheng VY, Nakazato R, Dey D et al (2009) Reproducibility of coronary artery plaque volume and composition quantification by 64-detector row coronary computed tomographic angiography: an intraobserver, interobserver, and interscan variability study. J Cardiovasc Comput Tomogr 3:312–320CrossRefPubMed Cheng VY, Nakazato R, Dey D et al (2009) Reproducibility of coronary artery plaque volume and composition quantification by 64-detector row coronary computed tomographic angiography: an intraobserver, interobserver, and interscan variability study. J Cardiovasc Comput Tomogr 3:312–320CrossRefPubMed
19.
Zurück zum Zitat Maroules CD, Hamilton-Craig C, Branch K et al (2018) Coronary artery disease reporting and data system (CAD-RADS(TM)): inter-observer agreement for assessment categories and modifiers. J Cardiovasc Comput Tomogr 12:125–130CrossRefPubMed Maroules CD, Hamilton-Craig C, Branch K et al (2018) Coronary artery disease reporting and data system (CAD-RADS(TM)): inter-observer agreement for assessment categories and modifiers. J Cardiovasc Comput Tomogr 12:125–130CrossRefPubMed
20.
Zurück zum Zitat Cury RC, Leipsic J, Abbara S et al (2022) CAD-RADS™ 2.0–2022 coronary artery disease-reporting and data system: an expert consensus document of the society of cardiovascular computed tomography (SCCT), the American College of Cardiology (ACC), the American College of Radiology (ACR), and the North America Society of Cardiovascular Imaging (NASCI). J Cardiovasc Comput Tomogr 16:536–557CrossRefPubMed Cury RC, Leipsic J, Abbara S et al (2022) CAD-RADS™ 2.0–2022 coronary artery disease-reporting and data system: an expert consensus document of the society of cardiovascular computed tomography (SCCT), the American College of Cardiology (ACC), the American College of Radiology (ACR), and the North America Society of Cardiovascular Imaging (NASCI). J Cardiovasc Comput Tomogr 16:536–557CrossRefPubMed
21.
Zurück zum Zitat Rinehart S, Vazquez G, Qian Z, Murrieta L, Christian K, Voros S (2011) Quantitative measurements of coronary arterial stenosis, plaque geometry, and composition are highly reproducible with a standardized coronary arterial computed tomographic approach in high-quality CT datasets. J Cardiovasc Comput Tomogr 5:35–43CrossRefPubMed Rinehart S, Vazquez G, Qian Z, Murrieta L, Christian K, Voros S (2011) Quantitative measurements of coronary arterial stenosis, plaque geometry, and composition are highly reproducible with a standardized coronary arterial computed tomographic approach in high-quality CT datasets. J Cardiovasc Comput Tomogr 5:35–43CrossRefPubMed
22.
Zurück zum Zitat Mancini GJ, Kamimura C, Yeoh E, Ryomoto A, Mazer CD (2022) Measurement of plaque characteristics using coronary computed tomography angiography: achieving high interobserver performance. CJC open 4:189–196CrossRefPubMed Mancini GJ, Kamimura C, Yeoh E, Ryomoto A, Mazer CD (2022) Measurement of plaque characteristics using coronary computed tomography angiography: achieving high interobserver performance. CJC open 4:189–196CrossRefPubMed
23.
Zurück zum Zitat Williams MC, Earls JP, Hecht H (2022) Quantitative assessment of atherosclerotic plaque, recent progress and current limitations. J Cardiovasc Comput Tomogr 16:124–137CrossRefPubMed Williams MC, Earls JP, Hecht H (2022) Quantitative assessment of atherosclerotic plaque, recent progress and current limitations. J Cardiovasc Comput Tomogr 16:124–137CrossRefPubMed
24.
Zurück zum Zitat Stone GW, Maehara A, Lansky AJ et al (2011) A prospective natural-history study of coronary atherosclerosis. N Engl J Med 364:226–235CrossRefPubMed Stone GW, Maehara A, Lansky AJ et al (2011) A prospective natural-history study of coronary atherosclerosis. N Engl J Med 364:226–235CrossRefPubMed
25.
Zurück zum Zitat Newby DE, Adamson PD, Berry C et al (2018) Coronary CT angiography and 5-Year risk of myocardial infarction. N Engl J Med 379:924–933CrossRefPubMed Newby DE, Adamson PD, Berry C et al (2018) Coronary CT angiography and 5-Year risk of myocardial infarction. N Engl J Med 379:924–933CrossRefPubMed
26.
Zurück zum Zitat Ferencik M, Mayrhofer T, Bittner DO et al (2018) Use of high-risk coronary atherosclerotic plaque detection for risk stratification of patients with stable chest pain: a secondary analysis of the PROMISE randomized clinical trial. JAMA Cardiol 3:144–152CrossRefPubMedPubMedCentral Ferencik M, Mayrhofer T, Bittner DO et al (2018) Use of high-risk coronary atherosclerotic plaque detection for risk stratification of patients with stable chest pain: a secondary analysis of the PROMISE randomized clinical trial. JAMA Cardiol 3:144–152CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Serruys PW, Hara H, Garg S et al (2021) Coronary computed tomographic angiography for complete assessment of coronary artery disease: JACC State-of-the-art review. J Am Coll Cardiol 78:713–736CrossRefPubMed Serruys PW, Hara H, Garg S et al (2021) Coronary computed tomographic angiography for complete assessment of coronary artery disease: JACC State-of-the-art review. J Am Coll Cardiol 78:713–736CrossRefPubMed
28.
Zurück zum Zitat Min JK, Dunning A, Lin FY et al (2011) Age- and sex-related differences in all-cause mortality risk based on coronary computed tomography angiography findings results from the international multicenter CONFIRM (coronary CT angiography evaluation for clinical outcomes: an international multicenter registry) of 23,854 patients without known coronary artery disease. J Am Coll Cardiol 58:849–860CrossRefPubMed Min JK, Dunning A, Lin FY et al (2011) Age- and sex-related differences in all-cause mortality risk based on coronary computed tomography angiography findings results from the international multicenter CONFIRM (coronary CT angiography evaluation for clinical outcomes: an international multicenter registry) of 23,854 patients without known coronary artery disease. J Am Coll Cardiol 58:849–860CrossRefPubMed
29.
Zurück zum Zitat Serruys PW, Kotoku N, Norgaard BL et al (2023) Computed tomographic angiography in coronary artery disease. EuorIntervention 18:e1307CrossRef Serruys PW, Kotoku N, Norgaard BL et al (2023) Computed tomographic angiography in coronary artery disease. EuorIntervention 18:e1307CrossRef
30.
Zurück zum Zitat Bergström G, Persson M, Adiels M et al (2021) Prevalence of subclinical coronary artery atherosclerosis in the general population. Circulation 144:916–929CrossRefPubMedPubMedCentral Bergström G, Persson M, Adiels M et al (2021) Prevalence of subclinical coronary artery atherosclerosis in the general population. Circulation 144:916–929CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat van Rosendael AR, Shaw LJ, Xie JX et al (2019) Superior risk stratification with coronary computed tomography angiography using a comprehensive atherosclerotic risk score. JACC Cardiovasc Imaging 12:1987–1997CrossRefPubMedPubMedCentral van Rosendael AR, Shaw LJ, Xie JX et al (2019) Superior risk stratification with coronary computed tomography angiography using a comprehensive atherosclerotic risk score. JACC Cardiovasc Imaging 12:1987–1997CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Gatti JW, De Araujo Gonçalves P, Garcia-Garcia HM (2020) Computed tomography angiography-based risk discrimination: an established bright future for prognostication. JACC Cardiovasc Imaging 13:1097–1098CrossRefPubMed Gatti JW, De Araujo Gonçalves P, Garcia-Garcia HM (2020) Computed tomography angiography-based risk discrimination: an established bright future for prognostication. JACC Cardiovasc Imaging 13:1097–1098CrossRefPubMed
Metadaten
Titel
Inter- and intra-observer reproducibility of CT-Leaman score by an independent core lab
verfasst von
Pruthvi C. Revaiah
Shigetaka Kageyama
Shinichiro Masuda
Kai Ninomiya
Nozomi Kotoku
Bo Wang
Xingqiang He
Tsung-Ying Tsai
Scot Garg
Saima Mushtaq
Johan H. C. Reiber
David M. Leaman
Jeroen J. Bax
Matthew J. Budoff
Daniele Andreini
Patrick W. Serruys
Yoshinobu Onuma
Publikationsdatum
24.10.2023
Verlag
Springer Netherlands
Erschienen in
The International Journal of Cardiovascular Imaging / Ausgabe 11/2023
Print ISSN: 1569-5794
Elektronische ISSN: 1875-8312
DOI
https://doi.org/10.1007/s10554-023-02962-3

Weitere Artikel der Ausgabe 11/2023

The International Journal of Cardiovascular Imaging 11/2023 Zur Ausgabe

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.